The continuoglucose monitoring market share is forecast to reach USD 2,588.61 million, after growing at a CAGR of 6.37% during 2023-2027. The rise in the diabetic population is analyzed to boost the continuoglucose monitoring market growth. Moreover, the increasing adoption of home healthcare devices is the major trend enhancing the overall market demand for continuoglucose monitoring during the forecast period.
Get a snapshot of the continuoglucose monitoring market analysis: Unlock the Sample Report The report includes historic market data from 2017 to 2021. In 2017, the market was valued at USD 5784.97 million.
Browse Technavio's 158-page report and in-depth TOC on "Continuoglucose Monitoring Market by Component (sensors, transmitters, and receivers), end-user (home care, hospitals, and others), and geography (North America, Europe, Asia, and Rest of World).
View detailed Table of Contents Here: https://www.technavio.com/report/continuoglucose-monitoring-market-analysis
Component:
Sensors: The market share growth by the sensors segment will be significant during the forecast period. Demand for glucose sensors is estimated to surge during the forecast period due to the rise in the prevalence of diabetes globally, aided by the surging geriatric population.
Transmitters
Receivers
Geography:
North America: 43% of market growth will develop from North America during the forecast period. The continuoglucose monitoring market in North America is growing at a steady pace owing to an increase in technological advances and a high incidence of type 1 and type 2 diabetes.
Europe
Asia
Rest of World (ROW)
End-user:
Home care
Hospitals
Others
The continuoglucose monitoring market size will witness a YOY Growth Rate of 5.61% in 2023.
The lower diagnosis and treatment rate will be a major challenge for the continuoglucose monitoring market during the forecast period.
Major key continuoglucose monitoring market players include: A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun SE, Dexcom Inc., F. Hoffmann La Roche Ltd., General Electric Co., GlySens Inc., Johnson and Johnson, LifeScan IP Holdings LLC, Medtronic Plc, Medtrum Technologies Inc., Novo Nordisk AS, NXP Semiconductors NV, Senseonics Holdings Inc., STMicroelectronics NV, Tandem Diabetes Care Inc., Terumo Corp., and Ypsomed AG
The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and Rest of World (ROW).
Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2023-2027.
CAGR of the continuoglucose monitoring market forecast during 2023-2027.
Market-level data on units, average selling prices, and values of the continuoglucose monitoring market share.
Prediction of the upcoming trends, drivers, and factors that challenge the growth of the continuoglucose monitoring market.
Continuoglucose monitoring industry growth across North America, Europe, Asia, and Rest of World (ROW).
